Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
801
American Financial Group
AFG
$11.7B
| $20.5M | 0.02% |
323,000
-33,951
| -10% | -$2.19M |
2017 Q1
13 quarters
|
|
802
Sterling Infrastructure
STRL
$15.7B
| $20.5M | 0.02% |
1,956,600
-131,000
| -6% | -$1.21M |
2013 Q2
28 quarters
|
|
803
Everest Group
EG
$14.1B
| $20.5M | 0.02% |
99,325
+60,320
| +155% | +$11.7M |
2015 Q3
19 quarters
|
|
804
PagerDuty
PD
$1.27B
| $20.4M | 0.02% |
713,800
+212,600
| +42% | +$5.13M |
2020 Q1
1 quarter
|
|
|
P
805
Everpure Inc
P
$51.5B
| $20.4M | 0.02% |
1,178,375
-1,152,863
| -49% | -$17.3M |
2016 Q4
14 quarters
|
|
|
BRKL
806
DELISTED
Brookline Bancorp
BRKL
| $20.4M | 0.02% |
2,023,112
-76,028
| -4% | -$759K |
2014 Q3
23 quarters
|
|
807
Gilat Satellite Networks
GILT
$689M
| $20.3M | 0.02% |
3,190,749
+127,520
| +4% | +$981K |
2013 Q2
28 quarters
|
|
808
Cracker Barrel
CBRL
$1.28B
| $20.3M | 0.02% |
183,132
-109,700
| -37% | -$10.9M |
2018 Q3
7 quarters
|
|
809
Cavco Industries
CVCO
$4.09B
| $20.3M | 0.02% |
105,245
-37,954
| -27% | -$6.22M |
2013 Q3
27 quarters
|
|
810
Fiverr
FVRR
$313M
| $20.3M | 0.02% |
274,400
+254,900
| +1,307% | +$13.1M |
2020 Q1
1 quarter
|
|
811
Moderna
MRNA
$89.8B
| $20.3M | 0.02% |
+315,400
| New | +$17.3M |
2020 Q2
0 quarters
|
|
812
eGain
EGAN
$139M
| $20.1M | 0.02% |
1,810,033
+230,912
| +15% | +$2.1M |
2015 Q3
19 quarters
|
|
|
WMGI
813
DELISTED
Wright Medical Group Inc
WMGI
| $20.1M | 0.02% |
676,407
+384,100
| +131% | +$11.2M |
2020 Q1
1 quarter
|
|
|
QIWI
814
DELISTED
QIWI PLC
QIWI
| $20.1M | 0.02% |
1,160,351
-838,000
| -42% | -$11.4M |
2014 Q3
23 quarters
|
|
815
Atlanta Braves Holdings Series B
BATRK
$3.34B
| $20M | 0.02% |
1,012,419
-1,000
| -0.1% | -$19.9K |
2017 Q1
13 quarters
|
|
816
CVB Financial
CVBF
$3.78B
| $19.9M | 0.02% |
1,063,400
-264,200
| -20% | -$5.04M |
2018 Q4
6 quarters
|
|
817
WEC Energy
WEC
$33.8B
| $19.9M | 0.02% |
226,975
-743,415
| -77% | -$67.1M |
2016 Q3
15 quarters
|
|
818
IMAX
IMAX
$2.79B
| $19.8M | 0.02% |
1,769,800
+428,300
| +32% | +$5.01M |
2018 Q2
8 quarters
|
|
819
Orthofix Medical
OFIX
$374M
| $19.8M | 0.02% |
619,369
+158,900
| +35% | +$5.27M |
2013 Q2
28 quarters
|
|
|
LSXMK
820
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $19.8M | 0.02% |
741,580
-476,209
| -39% | -$12.3M |
2017 Q1
13 quarters
|
|
|
LEG
821
DELISTED
Leggett & Platt
LEG
| $19.8M | 0.02% |
562,500
+23,250
| +4% | +$721K |
2019 Q4
2 quarters
|
|
822
Grand Canyon Education
LOPE
$4.17B
| $19.8M | 0.02% |
218,387
+136,300
| +166% | +$12.1M |
2020 Q1
1 quarter
|
|
823
Barrett Business Services
BBSI
$769M
| $19.7M | 0.02% |
1,482,000
-144,400
| -9% | -$1.67M |
2013 Q2
28 quarters
|
|
824
Village Super Market
VLGEA
$652M
| $19.7M | 0.02% |
709,885
+57,285
| +9% | +$1.38M |
2013 Q2
28 quarters
|
|
825
The RMR Group
RMR
$302M
| $19.7M | 0.02% |
667,616
+16,900
| +3% | +$489K |
2016 Q2
16 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.